NFKB1 and metabolic dysfunction-associated steatotic liver disease: The results indicate that GLC administration may attenuate the inflammatory process in the livers of HFHSD-fed NAFLD mice by regulating the TLR4/NF-κB pathway and regulating the expression of related inflammatory factors in the pathway.